{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:31:53Z","timestamp":1788471113033,"version":"build-2803163510"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2018R1D1A1A09081961"],"award-info":[{"award-number":["2018R1D1A1A09081961"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Tc-99m sestamibi single-photon emission computed tomography\/computed tomography (SPECT\/CT) has been used to help surgeons explore the location of parathyroid diseases, but quantitative parameters have not been systemically investigated for this purpose. We aimed to establish objective criteria for adenoma and hyperplasia using the standardized uptake value (SUV) in patients with hyperparathyroidism.<\/jats:p>\n            <jats:p>Thirty-nine hyperparathyroid patients (male\/female: 17\/22, age: 58.33\u200a\u00b1\u200a11.69 years) with at least 1 uptake-positive lesion of any degree by visual assessment in preoperative Tc-99m sestamibi quantitative SPECT\/CT were included from Oct 2015 to Oct 2017. Pathologically, 44 lesions (32 adenomas and 12 hyperplasia) were identified. All patients experienced normalized levels of intact parathyroid hormone immediately after surgery. Quantitative SPECT\/CT was performed at 10\u200aminute and 2\u200ahour post injection of Tc-99m sestabmibi (dose\u200a=\u200a740 MBq), and maximum SUV (SUVmax) was measured for the parathyroid lesions. Experienced pathologists evaluated the percentage cellular proportions of chief cells, oxyphil cells, and clear cells.<\/jats:p>\n            <jats:p>SUVmax (g\/mL) of adenomas, hyperplasia, and reference thyroid tissue were 12.92\u200a\u00b1\u200a6.68, 7.90\u200a\u00b1\u200a5.49, and 7.01\u200a\u00b1\u200a2.62 at 10min (early phase), decreasing to 7.46\u200a\u00b1\u200a5.66, 4.65\u200a\u00b1\u200a3.14, and 2.21\u200a\u00b1\u200a1.07 at 2\u200ahour (delayed phase), respectively. The adenomas showed significantly higher SUVmax than both the hyperplasia (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0131) and reference thyroid tissue (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.0001) along the early and delayed phases, but the SUVmax of the hyperplasia did not differ from that of the reference thyroid tissue (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.4196). The adenomas and hyperplasia were discriminated from the reference thyroid tissue using a cutoff SUVmax of 3.26 at the delayed phase. The adenomas had lower %proportions of oxyphil cells than the hyperplasia (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0054), but its SUVmax at the delayed phase was positively correlated with the %proportions of mitochondria-abundant oxyphil cells (rho\u200a=\u200a0.418, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0173). The hyperplasia showed no correlation between SUVmax and cellular proportions.<\/jats:p>\n            <jats:p>SUVmax at the delayed phase in the Tc-99m sestamibi quantitative SPECT\/CT was useful for the identification and differentiation of parathyroid lesions causing hyperparathyroidism.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021176","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T09:02:59Z","timestamp":1594285379000},"page":"e21176","source":"Crossref","is-referenced-by-count":13,"title":["The Usefulness of Maximum Standardized Uptake Value at the Delayed Phase of Tc-99m sestamibi single-photon emission computed tomography\/computed tomography for Identification of Parathyroid Adenoma and Hyperplasia"],"prefix":"10.1097","volume":"99","author":[{"given":"Hoon Young","family":"Suh","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine"},{"name":"Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"So","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Konkuk University Medical Center, Konkuk University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine"},{"name":"Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","article-title":"A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003","volume":"132","author":"Ruda","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1158\/1078-0432.CCR-17-0548","article-title":"Multiple endocrine neoplasia and hyperparathyroid-jaw tumor syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Wasserman","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary Hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.clinthera.2004.12.011","article-title":"Secondary hyperparathyroidism: review of the disease and its treatment","volume":"26","author":"de Francisco","year":"2004","journal-title":"Clin Ther"},{"issue":"(Suppl 5)","key":"R6-20230915","doi-asserted-by":"crossref","first-page":"V15","DOI":"10.1093\/ndt\/gfh1051","article-title":"The need for better control of secondary hyperparathyroidism","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2967\/jnmt.112.105122","article-title":"SNM practice guideline for parathyroid scintigraphy 4.0","volume":"40","author":"Greenspan","year":"2012","journal-title":"J Nucl Med Technol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/00006231-198911000-00003","article-title":"99Tcm sestamibi--a new agent for parathyroid imaging","volume":"10","author":"Coakley","year":"1989","journal-title":"Nucl Med Commun"},{"key":"R11-20230915","first-page":"313","article-title":"Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies","volume":"33","author":"O\u2019Doherty","year":"1992","journal-title":"J Nucl Med"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00268-005-7849-2","article-title":"Technetium-99m-MIBI SPECT\/CT in primary hyperparathyroidism","volume":"30","author":"Krausz","year":"2006","journal-title":"World J Surg"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/RLU.0b013e3181b591c9","article-title":"Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy","volume":"34","author":"Thomas","year":"2009","journal-title":"Clin Nucl Med"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/RLU.0b013e31823362e5","article-title":"Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT\/CT in primary hyperparathyroidism: a single-institution experience","volume":"37","author":"Ciappuccini","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2967\/jnumed.107.040428","article-title":"Comparison of SPECT\/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy","volume":"48","author":"Lavely","year":"2007","journal-title":"J Nucl Med"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1148\/radiol.2481071066","article-title":"Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings","volume":"248","author":"Nichols","year":"2008","journal-title":"Radiology"},{"key":"R17-20230915","first-page":"127","article-title":"Comparison of SPET\/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: a meta-analysis","volume":"18","author":"Wei","year":"2015","journal-title":"Hell J Nucl Med"},{"key":"R18-20230915","first-page":"1801","article-title":"Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study)","volume":"33","author":"Taillefer","year":"1992","journal-title":"J Nucl Med"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2967\/jnumed.112.111476","article-title":"An evidence-based review of quantitative SPECT imaging and potential clinical applications","volume":"54","author":"Bailey","year":"2013","journal-title":"J Nucl Med"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/2191-219X-3-45","article-title":"Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT\/CT","volume":"3","author":"Cachovan","year":"2013","journal-title":"EJNMMI Res"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1148\/radiol.2016152294","article-title":"Maximum standardized uptake value of (99m)Tc Hydroxymethylene Diphosphonate SPECT\/CT for the evaluation of temporomandibular joint disorder","volume":"280","author":"Suh","year":"2016","journal-title":"Radiology"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"e4170","DOI":"10.1097\/MD.0000000000004170","article-title":"Quantitative single-photon emission computed tomography\/computed tomography for technetium pertechnetate thyroid uptake measurement","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.crad.2017.03.009","article-title":"Maximum standardised uptake value of quantitative bone SPECT\/CT in patients with medial compartment osteoarthritis of the knee","volume":"72","author":"Kim","year":"2017","journal-title":"Clin Radiol"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3348\/kjr.2017.18.3.543","article-title":"Novel application of quantitative single-photon emission computed tomography\/computed tomography to predict early response to methimazole in graves\u2019 disease","volume":"18","author":"Kim","year":"2017","journal-title":"Korean J Radiol"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s13139-017-0491-8","article-title":"Quantitative single-photon emission computed tomography\/computed tomography for glomerular filtration rate measurement","volume":"51","author":"Kang","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3348\/kjr.2018.19.3.470","article-title":"Utility of quantitative parameters from single-photon emission computed tomography\/computed tomography in patients with destructive thyroiditis","volume":"19","author":"Kim","year":"2018","journal-title":"Korean J Radiol"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s13139-018-0547-4","article-title":"Quantitative single-photon emission computed tomography\/computed tomography for evaluation of salivary gland dysfunction in sjogren's syndrome patients","volume":"52","author":"Kim","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s13139-018-0554-5","article-title":"Evaluation of hot nodules of thyroid gland using Tc-99m Pertechnetate: a novel approach using quantitative single-photon emission computed tomography\/computed tomography","volume":"52","author":"Lee","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.1097\/MD.0000000000014022","article-title":"Maximum standardized uptake value of foot SPECT\/CT using Tc-99m HDP in patients with accessory navicular bone as a predictor of surgical treatment","volume":"98","author":"Bae","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13139-019-00600-2","article-title":"Minimum standardized uptake value from quantitative bone single-photon emission computed tomography\/computed tomography for evaluation of femoral head viability in patients with femoral neck fracture","volume":"53","author":"Ryoo","year":"2019","journal-title":"Nucl Med Mol Imaging"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13139-019-00588-9","article-title":"Clinical applications of technetium-99m quantitative single-photon emission computed tomography\/computed tomography","volume":"53","author":"Lee","year":"2019","journal-title":"Nucl Med Mol Imaging"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1148\/radiographics.19.3.g99ma10601","article-title":"Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy","volume":"19","author":"Nguyen","year":"1999","journal-title":"Radiographics"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jcp.2002.002550","article-title":"Best practice no 183, Examination of parathyroid gland specimens","volume":"58","author":"Johnson","year":"2005","journal-title":"J Clin Pathol"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2214\/AJR.06.0938","article-title":"Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism","volume":"188","author":"Johnson","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1148\/radiol.2015142393","article-title":"Parathyroid adenomas and hyperplasia on four-dimensional CT scans: three patterns of enhancement relative to the thyroid gland justify a three-phase protocol","volume":"277","author":"Bahl","year":"2015","journal-title":"Radiology"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6823-7-8","article-title":"Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas","volume":"7","author":"Costa-Guda","year":"2007","journal-title":"BMC Endocr Disord"},{"key":"R37-20230915","first-page":"1646","article-title":"Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts","volume":"31","author":"Chiu","year":"1990","journal-title":"J Nucl Med"},{"key":"R38-20230915","first-page":"1551","article-title":"Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines","volume":"37","author":"Arbab","year":"1996","journal-title":"J Nucl Med"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/dc.20115","article-title":"Oncocytic parathyroid adenoma: problem in cytological diagnosis","volume":"31","author":"Giorgadze","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.anorl.2015.08.033","article-title":"Oncocytic parathyroid adenoma","volume":"132","author":"Paul","year":"2015","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"R41-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MNM.0000000000000761","article-title":"Dual time-point quantitative SPECT-CT parathyroid imaging using a single computed tomography: feasibility and operator variability","volume":"39","author":"Razavi","year":"2018","journal-title":"Nucl Med Commun"},{"key":"R42-20230915","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MNM.0000000000000996","article-title":"Quantitative analysis of technetium-99m-sestamibi uptake and washout in parathyroid scintigraphy supports dual mechanisms of lesion conspicuity","volume":"40","author":"Robin","year":"2019","journal-title":"Nucl Med Commun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:36:02Z","timestamp":1694828162000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":42,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021176","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]}}}